☆ 4.7 Review

Emerging SARS-CoV-2 variants of concern and potential intervention approaches

CRITICAL CARE (2021)

Related references

Note: Only part of the references are listed.

Article Virology

Analysis of SARS-CoV-2 mutations in Mexico, Belize, and isolated regions of Guatemala and its implication in the diagnosis

Teresa Hernandez-Huerta Maria et al.

Summary: The study analyzed mutations in the genomic sequences of SARS-CoV-2 in Mexico, Belize, and Guatemala, finding several variants related to a more infectious strain of the virus, potentially leading to increased spread in these countries and impacting diagnosis.

JOURNAL OF MEDICAL VIROLOGY (2021)

Add to Collection

Article Multidisciplinary Sciences

Spike mutation D614G alters SARS-CoV-2 fitness

Jessica A. Plante et al.

Summary: The D614G substitution in the SARS-CoV-2 spike protein enhances viral replication and infectivity in human lung epithelial cells, primary airway tissues, and hamsters. This variant may increase transmission in the upper respiratory tract and doesn't seem to significantly reduce vaccine efficacy. Further research on therapeutic antibodies targeting the circulating G614 virus is recommended.

NATURE (2021)

Add to Collection

Article Infectious Diseases

Two-step strategy for the identification of SARS-CoV-2 variant of concern 202012/01 and other variants with spike deletion H69-V70, France, August to December 2020

Antonin Bal et al.

Summary: The study reported the strategy leading to the first detection of the variant of concern 202012/01 (VOC) in France, by screening for mutations such as Delta H69/Delta V70 associated with VOC and identifying co-occurring mutations like S:N501Y.

EUROSURVEILLANCE (2021)

Add to Collection

Article Infectious Diseases

Analysis of the potential impact of genomic variants in global SARS-CoV-2 genomes on molecular diagnostic assays

Abhinav Jain et al.

Summary: The SARS-CoV-2 epidemic originating from Wuhan rapidly evolved into a global pandemic, highlighting the importance of molecular detection using RT-PCR, although mutations in the viral genome could impact the accuracy of detection assays. The analysis of global SARS-CoV-2 genomes identified multiple genetic variants that could affect the effectiveness of diagnostic primers and probes.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2021)

Add to Collection

Article Multidisciplinary Sciences

Structure of SARS-CoV-2 ORF8, a rapidly evolving immune evasion protein

Thomas G. Flower et al.

Summary: The crystal structure of SARS-CoV-2 ORF8 was determined at 2.04-angstrom resolution by X-ray crystallography, revealing unique dimerization interfaces that may allow the protein to form large-scale assemblies, potentially mediating immune suppression and evasion activities.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

Add to Collection

Article Multidisciplinary Sciences

Prospective mapping of viral mutations that escape antibodies used to treat COVID-19

Tyler N. Starr et al.

Summary: Research has found that mutations in the receptor binding domain (RBD) of SARS-CoV-2 may potentially escape the action of the REGN-COV2 cocktail, providing important information for interpreting mutations observed during viral surveillance.

SCIENCE (2021)

Add to Collection

Review Biotechnology & Applied Microbiology

Perspective on therapeutic and diagnostic potential of camel nanobodies for coronavirus disease-19 (COVID-19)

Salma Bessalah et al.

Summary: Nanobodies, as a revolutionary therapy for COVID-19, have the potential to guide drug discovery efforts. Their small size and strong antigen affinity make them effective in treating and preventing SARS-CoV-2 infection, controlling disease transmission and development.

3 BIOTECH (2021)

Add to Collection

Article Chemistry, Analytical

Detection of SARS-CoV-2 and Its Mutated Variants via CRISPR-Cas13-Based Transcription Amplification

Yuxi Wang et al.

Summary: The detection method using light-up CRISPR-Cas13 technology can sensitively and accurately detect SARS-CoV-2 and its mutated variants, with high specificity and sensitivity, allowing for strict discrimination of key mutations.

ANALYTICAL CHEMISTRY (2021)

Add to Collection

Article Microbiology

Genomic monitoring of SARS-CoV-2 uncovers an Nsp1 deletion variant that modulates type I interferon response

Jing-wen Lin et al.

Summary: This study utilized an integrative approach to analyze mutations of the SARS-CoV-2 virus, identifying 35 recurrent variants of clinical importance, with one variant associated with severe clinical phenotypes. The findings suggest that mutations in Nsp1 may have implications for molecular diagnostics and drug design.

CELL HOST & MICROBE (2021)

Add to Collection

Letter Medicine, General & Internal

Emergence of a Novel SARS-CoV-2 Variant in Southern California

Wenjuan Zhang et al.

Summary: The research focused on sequencing and phylogenetic analyses of SARS-CoV-2 isolates from symptomatic patients at Cedar-Sinai Medical Center in November-December 2020, providing insights into a surge in cases and hospitalizations during that period.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Add to Collection

Editorial Material Virology

Will the emergent SARS-CoV2 B.1.1.7 lineage affect molecular diagnosis of COVID-19?

Juan D. Ramirez et al.

Summary: As the COVID-19 pandemic continues to affect global public health systems, mutations in the SARS-CoV2 genome are being observed. The emergence of the B.1.1.7 lineage in the UK has raised concerns among global authorities due to potential challenges it may pose to diagnostic testing. Efforts must be made to closely monitor SARS-CoV-2 genomes for variants that could impact testing accuracy and lead to false negative results.

JOURNAL OF MEDICAL VIROLOGY (2021)

Add to Collection

Article Urology & Nephrology

A Novel Soluble ACE2 Variant with Prolonged Duration of Action Neutralizes SARS-CoV-2 Infection in Human Kidney Organoids

Jan Wysocki et al.

Summary: A novel ACE2 variant has been developed that can neutralize SARS-CoV-2 infectivity in human kidney organoids, with prolonged duration of action and potential for improved efficacy.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2021)

Add to Collection

Article Multidisciplinary Sciences

SARS-CoV-2 spike D614G change enhances replication and transmission

Bin Zhou et al.

Summary: Research has shown that the D614G substitution in the spike protein of SARS-CoV-2 leads to increased binding and replication potential in humans, as well as significantly higher replication and transmissibility in different animal models, providing an explanation for the global prevalence of this variant in the COVID-19 pandemic.

NATURE (2021)

Add to Collection

Letter Medicine, General & Internal

Serum Neutralizing Activity Elicited by mRNA-1273 Vaccine

Kai Wu et al.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Letter Medicine, General & Internal

Neutralizing Activity of BNT162b2-Elicited Serum

Yang Liu et al.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Article Virology

Inhibitors of endosomal acidification suppress SARS-CoV-2 replication and relieve viral pneumonia in hACE2 transgenic mice

Chao Shang et al.

Summary: This study found that endosomal acidification inhibitors, including chloroquine, bafilomycin A1, and NH4Cl, significantly reduced the viral yields of SARS-CoV-2 in various cell lines and in a transgenic mouse model. These inhibitors also improved cell viability post-infection and alleviated viral pneumonia in mice, suggesting potential therapeutic benefits in treating COVID-19.

VIROLOGY JOURNAL (2021)

Add to Collection

Article Multidisciplinary Sciences

Targeting androgen regulation of TMPRSS2 and ACE2 as a therapeutic strategy to combat COVID-19

Qu Deng et al.

Summary: The study suggests a potential role of androgen in SARS-CoV-2 infection by regulating ACE2 and TMPRSS2 transcription. Camostat, a TMPRSS2 inhibitor, blocks the cleavage of SARS-CoV-2 Spike protein, providing evidence of TMPRSS2's direct role in viral fusion to host cells. Androgen-deprivation, anti-androgens, or camostat attenuate SARS-CoV-2 cellular entry, highlighting the importance of TMPRSS2 inhibitors and androgen-deprivation therapy in preventing COVID-19 progression.

ISCIENCE (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Transmission, infectivity, and neutralization of a spike L452R SARS-CoV-2 variant

Xianding Deng et al.

Summary: A new SARS-CoV-2 variant named B.1.427/B.1.429 was identified in California, with increased transmissibility and carrying three mutations in spike protein, including L452R substitution. The variant emerged in May 2020 and became predominant in sequenced cases from September 2020 to January 2021. In vivo viral shedding was increased and antibody neutralization decreased, calling for further investigation.

CELL (2021)

Add to Collection

Article Multidisciplinary Sciences

Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England

Erik Volz et al.

Summary: Genetic and testing data from England indicate that the SARS-CoV-2 variant B.1.1.7 has a transmission advantage over other lineages, showing a rapid expansion during autumn 2020. Analysis of S gene target failures (SGTF) in community-based diagnostic PCR testing suggests that B.1.1.7 is more transmissible than non-variant of concern lineages and has a significant transmission advantage, with a reproduction number 50% to 100% higher. Additionally, cases of B.1.1.7 appear to include a larger share of under 20-year-olds compared to non-variant cases.

NATURE (2021)

Add to Collection

Article Medicine, General & Internal

Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant

S. A. Madhi et al.

Summary: The ChAdOx1 nCoV-19 vaccine did not provide significant protection against mild-to-moderate Covid-19 caused by the B.1.351 variant, with an efficacy of 10.4%. The incidence of serious adverse events was balanced between the vaccine and placebo groups.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Review Biochemistry & Molecular Biology

Antiviral peptides against Coronaviridae family: A review

Hamid Heydari et al.

Summary: The Coronaviridae family comprises various viruses infecting humans, causing significant public health and economic burdens. With increasing viral resistance, the development of new drugs and vaccines becomes challenging. Antiviral peptides, as a type of antiviral drugs, show broad-spectrum activity and minimal side effects, offering promising therapeutic potential.

PEPTIDES (2021)

Add to Collection

Article Virology

Transmission dynamics and evolutionary history of 2019-nCoV

Xingguang Li et al.

JOURNAL OF MEDICAL VIROLOGY (2020)

Add to Collection

Article Virology

The first two cases of 2019-nCoV in Italy: Where they come from?

Marta Giovanetti et al.

JOURNAL OF MEDICAL VIROLOGY (2020)

Add to Collection

Article Multidisciplinary Sciences

A new coronavirus associated with human respiratory disease in China

Fan Wu et al.

NATURE (2020)

Add to Collection

Article Multidisciplinary Sciences

Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2

Renhong Yan et al.

SCIENCE (2020)

Add to Collection

Letter Medicine, General & Internal

Open access epidemiologic data and an interactive dashboard to monitor the COVID-19 outbreak in Canada

Isha Berry et al.

CANADIAN MEDICAL ASSOCIATION JOURNAL (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Development of CRISPR as an Antiviral Strategy to Combat SARS-CoV-2 and Influenza

Timothy R. Abbott et al.

CELL (2020)

Add to Collection

Article Immunology

Key residues of the receptor binding motif in the spike protein of SARS-CoV-2 that interact with ACE2 and neutralizing antibodies

Chunyan Yi et al.

CELLULAR & MOLECULAR IMMUNOLOGY (2020)

Add to Collection

Article Medicine, Research & Experimental

Emerging SARS-CoV-2 mutation hot spots include a novel RNA-dependent-RNA polymerase variant

Maria Pachetti et al.

JOURNAL OF TRANSLATIONAL MEDICINE (2020)

Add to Collection

Article Multidisciplinary Sciences

Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor

Jun Lan et al.

NATURE (2020)

Add to Collection

Article Multidisciplinary Sciences

Structural basis of receptor recognition by SARS-CoV-2

Jian Shang et al.

NATURE (2020)

Add to Collection

Review Chemistry, Multidisciplinary

Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19

Yuan Huang et al.

ACTA PHARMACOLOGICA SINICA (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding

Tyler N. Starr et al.

CELL (2020)

Add to Collection

Editorial Material Biochemistry & Molecular Biology

Making Sense of Mutation: What D614G Means for the COVID-19 Pandemic Remains Unclear

Nathan D. Grubaugh et al.

CELL (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus

Bette Korber et al.

CELL (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Use of Whole Genome Sequencing Data for a First in Silico Specificity Evaluation of the RT-qPCR Assays Used for SARS-CoV-2 Detection

Mathieu Gand et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Add to Collection

Article Multidisciplinary Sciences

Presence of mismatches between diagnostic PCR assays and coronavirus SARS-CoV-2 genome

Kashif Aziz Khan et al.

ROYAL SOCIETY OPEN SCIENCE (2020)

Add to Collection

Article Microbiology

Analytical sensitivity and efficiency comparisons of SARS-CoV-2 RT-qPCR primer-probe sets

Chantal B. F. Vogels et al.

NATURE MICROBIOLOGY (2020)

Add to Collection

Editorial Material Biochemistry & Molecular Biology

Chemosensory Dysfunction in COVID-19: Integration of Genetic and Epidemiological Data Points to D614G Spike Protein Variant as a Contributing Factor

Rafal Butowt et al.

ACS CHEMICAL NEUROSCIENCE (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology

Luca Piccoli et al.

CELL (2020)

Add to Collection

Review Pharmacology & Pharmacy

COVID-19 update: The race to therapeutic development

Julianne D. Twomey et al.

DRUG RESISTANCE UPDATES (2020)

Add to Collection

Article Multidisciplinary Sciences

Engineering human ACE2 to optimize binding to the spike protein of SARS coronavirus 2

Kui K. Chan et al.

SCIENCE (2020)

Add to Collection

Article Infectious Diseases

Emergence of genomic diversity and recurrent mutations in SARS-CoV-2

Lucy van Dorp et al.

INFECTION GENETICS AND EVOLUTION (2020)

Add to Collection

Article Virology

Assessing oligonucleotide designs from early lab developed PCR diagnostic tests for SARS-CoV-2 using the PCR_strainer pipeline

Kevin S. Kuchinski et al.

JOURNAL OF CLINICAL VIROLOGY (2020)

Add to Collection

Article Medicine, General & Internal

Effects of a major deletion in the SARS-CoV-2 genome on the severity of infection and the inflammatory response: an observational cohort study

Barnaby E. Young et al.

LANCET (2020)

Add to Collection

Article Cell Biology

Evasion of Type I Interferon by SARS-CoV-2

Hongjie Xia et al.

CELL REPORTS (2020)

Add to Collection

Article Virology

Temporal signal and the phylodynamic threshold of SARS-CoV-2

Sebastian Duchene et al.

VIRUS EVOLUTION (2020)

Add to Collection

Article Multidisciplinary Sciences

SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity

Lizhou Zhang et al.

NATURE COMMUNICATIONS (2020)

Add to Collection

Article Immunology

SARS-CoV-2 genomic surveillance in Taiwan revealed novel ORF8-deletion mutant and clade possibly associated with infections in Middle East

Yu-Nong Gong et al.

EMERGING MICROBES & INFECTIONS (2020)

Add to Collection

Article Multidisciplinary Sciences

SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivo

Yixuan J. Hou et al.

SCIENCE (2020)

Add to Collection

Article Infectious Diseases

Evolutionary dynamics of the SARS-CoV-2 ORF8 accessory gene

Filipe Pereira

INFECTION GENETICS AND EVOLUTION (2020)

Add to Collection

Article Microbiology

Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease

Maria L. Agostini et al.

MBIO (2018)

Add to Collection

Article Multidisciplinary Sciences

The mechanism of resistance to favipiravir in influenza

Daniel H. Goldhill et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)

Add to Collection

Editorial Material Infectious Diseases

GISAID: Global initiative on sharing all influenza data - from vision to reality

Yuelong Shu et al.

EUROSURVEILLANCE (2017)

Add to Collection

Article Microbiology

Newly Emerging Mutations in the Matrix Genes of the Human Influenza A(H1N1)pdm09 and A(H3N2) Viruses Reduce the Detection Sensitivity of Real-Time Reverse Transcription-PCR

Ji-Rong Yang et al.

JOURNAL OF CLINICAL MICROBIOLOGY (2014)

Add to Collection

Article Pharmacology & Pharmacy

TACE antagonists blocking ACE2 shedding caused by the spike protein of SARS-CoV are candidate antiviral compounds

Shiori Haga et al.

ANTIVIRAL RESEARCH (2010)

Add to Collection

Article Endocrinology & Metabolism

ACE and ACE2 activity in diabetic mice

Jan Wysocki et al.

DIABETES (2006)

Add to Collection

Article Multidisciplinary Sciences

Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus

WH Li et al.

NATURE (2003)

Add to Collection

© Peeref 2019-2024. All rights reserved.